Sheng Fong
Sheng Fong
Geriatric Medicine Residency, Singapore Health Services
Verified email at mohh.com.sg
Title
Cited by
Cited by
Year
Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing
J Gruber, S Fong, CB Chen, S Yoong, G Pastorin, S Schaffer, I Cheah, ...
Biotechnology advances 31 (5), 563-592, 2013
1112013
Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditiselegans?
PBL Pun, J Gruber, SY Tang, S Schaffer, RLS Ong, S Fong, LF Ng, ...
Biogerontology 11 (1), 17-30, 2010
952010
Mitochondrial changes in ageing Caenorhabditis elegans–what do we learn from superoxide dismutase knockouts?
J Gruber, LF Ng, S Fong, YT Wong, SA Koh, CB Chen, G Shui, ...
PloS one 6 (5), e19444, 2011
722011
The effect of dichloroacetate on health-and lifespan in C. elegans
S Schaffer, J Gruber, LF Ng, S Fong, YT Wong, SY Tang, B Halliwell
Biogerontology 12 (3), 195-209, 2011
402011
Caenorhabditis elegans: What We Can and Cannot Learn from Aging Worms
J Gruber, CB Chen, S Fong, LF Ng, E Teo, B Halliwell
Antioxidants & redox signaling 23 (3), 256-279, 2015
352015
Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease model
S Fong, E Teo, LF Ng, CB Chen, LN Lakshmanan, SY Tsoi, PK Moore, ...
Scientific reports 6, 33781, 2016
322016
Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta
E Teo, S Ravi, D Barardo, HS Kim, S Fong, A Cazenave-Gassiot, TY Tan, ...
Elife 8, e50069, 2019
142019
Identification of a previously undetected metabolic defect in the Complex II Caenorhabditis elegans mev-1 mutant strain using respiratory control analysis
S Fong, LF Ng, LT Ng, PK Moore, B Halliwell, J Gruber
Biogerontology 18 (2), 189-200, 2017
142017
Measuring reactive oxygen species in C. elegans using DCFDA—a word of caution
S Fong, J Gruber, B Halliwell
Worm Breeder’s Gaz 18 (11), 2010
122010
Drug synergy as a strategy for compression of morbidity in a Caenorhabditis elegans model of alzheimer’s disease
E Teo, S Fong, N Tolwinski, J Gruber
GeroScience, 1-8, 2020
12020
A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer’s disease
E Teo, SYJ Lim, S Fong, A Larbi, GD Wright, N Tolwinski, J Gruber
Translational Medicine of Aging 4, 11-21, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–11